Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 114 of 114, showing 5 Applications out of 570 total, starting on record 566, ending on 570

# Protocol No Study Title Investigator(s) & Site(s)

566.

ECCT/26/02/01   E-MASTER STUDY: PHASE 1
      Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1)        
Principal Investigator(s)
1. Zahida Qureshi
2. Alfred Osoti
3. George Gwako
Site(s) in Kenya
1. Mbagathi County Referral Hospital (Nairobi City county)
 
View

567.

ECCT/26/02/04   RSV IMPACT TRIAL
    A Phase-IIIb individually randomized, placebo-controlled trial on safety of RSVA/B-preF vaccine in pregnant women and efficacy against severe RSV-associated lower respiratory tract infection (LRTI) in infants.   
Principal Investigator(s)
1. Joyce Uchi Nyiro
2. Makobu Kimani
Site(s) in Kenya
1. Kilifi, KEMRI-Centre for Geographic Medicine Research Coast (CGMRC) (Kilifi county)
 
View

568.

ECCT/26/02/08   SOAR Study
    Optimizing Smoking Cessation and Unhealthy Alcohol Use Treatment Among People Living with Human Immunodeficiency Virus (PLWH) In Nairobi, Kenya   Abbreviated as SOAR Study   Smoking cessation Optimization and unhealthy Alcohol use Research, SOAR, Study.       
Principal Investigator(s)
1. DR. EMILY KOECH
Site(s) in Kenya
Riruta Hospital
 
View

569.

ECCT/26/03/02   E-MASTER STUDY: PHASE 1
    Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1)   
Principal Investigator(s)
1. Zahida Qureshi
2. Alfred Osoti
3. George Gwako
Site(s) in Kenya
1. St Marys Mission Hospital-Langata (Nairobi City county)
2. Mbagathi County Referral Hospital (Nairobi City county)
 
View

570.

ECCT/26/04/02   IGHID 12430/DELIVER-02
    IGHID12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY   
Principal Investigator(s)
1. Charity Wambui Kanyoro
Site(s) in Kenya
1. Moi University Clinical Research Centre(MUCRC), Eldoret, Kenya (Uasin Gishu county)
2. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county)
 
View